Pharma: GSK stops research on cough medicine
⚡ Quick Summary
GSK PLc is ending development of the chronic cough drug Camlipixant after mixed study results. Investors react with disappointment and the shares lose significant value.
📰 Related Articles
n-tv
Handelsblatt
Humpback whale in the Baltic Sea: Whale spotted near Heiligenhafen off the German Baltic Sea coast
Handelsblatt
Manufacturer recalls Lidl frozen berry mix due to suspected norovirus
Der Spiegel